HealthDay – MONDAY, May 25 (HealthDay News) — The use of the drug bevacizumab
(Avastin) in combination with chemotherapy greatly increases the risk of
gastrointestinal perforations in cancer patients, new research has
found.
|
Whole Body Vibration Review Get information on whole body vibration systems.
|
 Subscribe RSS Feed
Comments Feed
|
